drugset / Trial / NCT05096312

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

NCT05096312

Phase 4 Completed 23 enrolled East Avenue Medical Center, Philippines
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Acne Vulgaris is one of the most common dermatologic diagnoses requiring long-term maintenance therapy. Promising results of oral zinc gluconate in improving acne vulgaris has been described. A randomized, double blind, placebo-controlled clinical trial was utilized for this study with the objective to assess the efficacy of oral zinc gluconate in the improvement of disease activity in acne vulgaris patients as measured by the inflammatory score and Global Acne Grading System (GAGS) score.

Timeline

Start
2018-12-21
Primary completion
2019-07-19
Completion
2019-07-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.3 % Topical
Comparator Benzoyl Peroxide Other / unclassified 2.5 % Topical

Indications